| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 05/03/1994 | US5308836 Pharmaceutical composition of stabilized [Leu13 ]-motilin-Hse |
| 05/03/1994 | US5308459 Biosynthetic cerebrospinal fluid control and method of use |
| 05/03/1994 | CA1329308C Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
| 05/03/1994 | CA1329307C Purification of monomeric interferon |
| 05/03/1994 | CA1329215C2 Process for the manufacture of nitrilotriacetic acid derivatives |
| 05/03/1994 | CA1329157C Method for activating gene technologically produced, heterologous, eucaryotic proteins comprising disulphide bridges after expression in procaryotes |
| 05/03/1994 | CA1329156C Immunoglobulin conjugates |
| 04/28/1994 | WO1994009155A1 Methods of detecting alzheimer's disease |
| 04/28/1994 | WO1994009027A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| 04/28/1994 | WO1994008711A1 Apparatus and method for multiple simultaneous synthesis |
| 04/28/1994 | WO1994008600A1 Inhibition of signal transduction molecules |
| 04/28/1994 | WO1994008599A1 Ion-pairing of drugs for improved efficacy and delivery |
| 04/28/1994 | CA2146869A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| 04/27/1994 | EP0594235A2 Method of purification of amylase, purified amylase so obtained and uses of purified amylase |
| 04/27/1994 | EP0594164A1 Method for peptide C-terminal fragment sequence analysis and apparatus for collecting peptide fragment |
| 04/27/1994 | EP0593868A1 PEG-interferon conjugates |
| 04/27/1994 | EP0593639A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same. |
| 04/27/1994 | EP0593501A1 Biocidal proteins |
| 04/27/1994 | EP0593443A1 Bioavailable iron-albumin compounds, a process for the preparation thereof and pharmaceutical compositions containing them |
| 04/27/1994 | EP0514442B1 N-phenyl n-acetamido glycinamides, preparation method and drugs containing them |
| 04/27/1994 | EP0485471B1 Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides |
| 04/27/1994 | CN1085913A Glucagon-like peptide and insulinotropin derivatives |
| 04/27/1994 | CN1085911A Peptide compounds |
| 04/27/1994 | CN1085803A Medicine for improving growth of liver cell and its method for production |
| 04/26/1994 | US5307287 Comparative molecular field analysis (COMFA) |
| 04/26/1994 | US5306811 Isolation by concentration or separation |
| 04/26/1994 | US5306809 Acid-labile linker molecules |
| 04/26/1994 | US5306781 Activation accomplished by reaction with a carbodiimide; useful in the C-terminal sequencing of a peptide |
| 04/26/1994 | US5306627 Genetic engineering |
| 04/26/1994 | US5306562 Xanthenylamide handle for use in peptide synthesis |
| 04/26/1994 | US5306492 Oligosaccharide conjugated to carrier protein |
| 04/26/1994 | CA1328948C Polypeptide compounds |
| 04/20/1994 | EP0592989A2 Process of the selective and quantitative removal or preparation of tumor necrosis factor (TNF) and/or lipopolysaccharides (LPS) of aqueous solutions |
| 04/20/1994 | EP0592968A1 Automated peptide synthesizer |
| 04/20/1994 | EP0592791A2 Tricyclic compounds and peptide derivatives thereof |
| 04/20/1994 | EP0592529A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 04/20/1994 | EP0592512A1 NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS |
| 04/20/1994 | EP0592421A1 COMPARATIVE MOLECULAR FIELD ANALYSIS (CoMFA). |
| 04/20/1994 | EP0433345B1 Peptide synthesis method and solid support for use in the method |
| 04/19/1994 | US5304671 Solid-liquid separation of suspension; no desalting; precipitation of acid salt; neutralization; hydrolysis |
| 04/19/1994 | US5304645 Resorufin derivatives |
| 04/19/1994 | US5304638 Protein separation medium |
| 04/19/1994 | US5304603 Polypeptide; androgen secretion stimulator |
| 04/19/1994 | US5304497 Method of forming N-protected amino acid thiohydantoins |
| 04/19/1994 | US5304470 Process for the enzymatic preparation of protected and unprotected di- and oligopeptides in aqueous solutions |
| 04/19/1994 | US5304464 Protein complex enhancing sperm motility |
| 04/19/1994 | US5304310 Forming solution in water and organic solvent, adjusting pH, adding sodium chloride, separating aqueous phase |
| 04/19/1994 | CA1328625C Purification process |
| 04/14/1994 | WO1994008239A1 Detection of antigens and nucleic acids |
| 04/14/1994 | WO1994008051A1 Complex combinatorial chemical libraries encoded with tags |
| 04/14/1994 | WO1994007912A1 Affinity purification methods involving amino acid mimetics as elution reagents |
| 04/14/1994 | WO1994007910A1 New reagents for peptide couplings |
| 04/14/1994 | WO1993024517A3 Peptide sub-library kits |
| 04/14/1994 | CA2146162A1 Affinity purification methods involving amino acid mimetics as elution reagents |
| 04/14/1994 | CA2124585A1 Detection of antigens and nucleic acids |
| 04/13/1994 | EP0592367A2 Phosphono/biaryl substituted dipeptide derivatives |
| 04/13/1994 | EP0592242A1 Fibrin sealant compositions and method for utilizing same |
| 04/13/1994 | EP0592026A1 Method for determining antigenic reactivity in urine |
| 04/13/1994 | EP0591431A1 Hepatitis c virus (hcv) polypeptides |
| 04/13/1994 | EP0591320A1 Suppressor t-cell hybridoma |
| 04/13/1994 | EP0538300B1 O-glycosylated ifn-alpha |
| 04/12/1994 | US5302703 For making antibodies or receptors to metabolism products of tetrahydrocannabinol for use in immunoassays |
| 04/12/1994 | US5302702 Chimeric fibroblast growth factors |
| 04/12/1994 | US5302699 Antitumorigenic protein, method of preparing it and antitumorigenic composition containing the protein as active component |
| 04/12/1994 | US5302582 Enkastins: new glycopeptides which act to inhibit enkephlinase, processes for their preparation, and their use as pharmaceutical products |
| 04/12/1994 | US5302532 Containing flocculant |
| 04/12/1994 | US5302518 In the presence of a heat shock protein |
| 04/12/1994 | US5302384 Administering to treat inflammation |
| 04/12/1994 | US5302370 Form complexes with rhenium and technetium |
| 04/12/1994 | CA1328540C Cyclic anticoagulant peptides |
| 04/12/1994 | CA1328539C Method of removing dodecyl sulfate from sodium dodecyl sulfate solubilized protein solutions |
| 04/12/1994 | CA1328538C Method of separating an organic solvent from a protein mixture |
| 04/12/1994 | CA1328537C2 Metal chelate resins |
| 04/09/1994 | CA2566574A1 Fibrin sealant compositions and method for utilizing same |
| 04/06/1994 | EP0590152A1 Peptides with tachykinin antagonist activity |
| 04/06/1994 | EP0590076A1 Production of human hemoglobin in transgenic pigs |
| 04/06/1994 | EP0590071A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-$g(b)1 BINDING MOLECULES AND USES THEREOF |
| 04/06/1994 | EP0590067A1 Microbially-produced antibody fragments and their conjugates |
| 04/06/1994 | EP0590048A1 Therapeutic fragments of von willebrand factor |
| 04/06/1994 | EP0590038A1 Amino acid derivative and bromoacetyl modified peptides |
| 04/06/1994 | EP0590012A1 Mutant proteolytic enzymes from bacillus |
| 04/06/1994 | EP0589943A1 Mycobacterium proteins and applications |
| 04/06/1994 | EP0589927A1 Protected amino-acid unit, its preparation and its use |
| 04/06/1994 | EP0589894A1 Insecticidally effective peptides |
| 04/06/1994 | EP0353295B1 Novel and improved antibodies for site specific attachment of compounds |
| 04/06/1994 | EP0229126B1 Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for purification, removal, inhibition or assay of the inhibitors |
| 04/06/1994 | CN1085024A High voltage square wave avalanche transistor pulse generator |
| 04/06/1994 | CN1084849A Dual action inhibitors |
| 04/05/1994 | US5300651 Indole NH-group blocked with tert-butoxycarbonyl, a-amino group with 9-fluoroenzylmethoxycarbonyl |
| 04/05/1994 | US5300564 Forming a glassy polymer in the presence of a reagent to trap the reagent; having a gas or liquid component in solution to diffuse through the pores; immobilized enzymes; detectors; pollution control; immunoassay |
| 04/05/1994 | US5300434 Determing collagen degradation in vivo |
| 04/05/1994 | US5300433 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 03/31/1994 | WO1994006825A1 Ureido-acetamide derivatives, preparation thereof and drugs containing same |
| 03/31/1994 | WO1994006822A1 Method of isolating biomolecules by ion exchange |
| 03/31/1994 | WO1994006821A1 A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use |
| 03/31/1994 | WO1994006820A1 Leukinferon preparation |
| 03/31/1994 | WO1994006471A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 03/31/1994 | WO1994006451A1 Synthesis of n-substituted oligomers |
| 03/31/1994 | WO1994000489A3 Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses |
| 03/31/1994 | DE4231914A1 Prepn. of protein-hydrolysates from animal and/or vegetable substrates - including a step of decomposing the substrate with an electrical discharge |